Literature DB >> 12574360

Associations of MHC ancestral haplotypes with resistance/susceptibility to AIDS disease development.

Pedro O Flores-Villanueva1, Houria Hendel, Sophie Caillat-Zucman, Jay Rappaport, Alberto Burgos-Tiburcio, Sebastien Bertin-Maghit, Jorge A Ruiz-Morales, Maria E Teran, Juan Rodriguez-Tafur, Jean-François Zagury.   

Abstract

We tested the association of MHC ancestral haplotypes with rapid or slow progression to AIDS by comparing their frequencies in the French genetics of resistance/susceptibility to immunodeficiency virus cohort with that reported in a control French population. Seven ancestral haplotypes were identified in the genetics of resistance/susceptibility to immunodeficiency virus cohort with a frequency >1%. The 8.1 (odds ratio (OR) = 3, p = 0.006), 35.1 (OR = 5.7, p = 0.001), and 44.2 (OR = 3.4, p = 0.007) ancestral haplotypes were associated with rapid progression, whereas the 35.2 (OR = 3.6, p = 0.001), 44.1 (OR = 5.4, p < 10(-4)), and 57.1 (OR = 5.8, p < 10(-4)) ancestral haplotypes were associated with slow progression to AIDS. Although the frequency of each ancestral haplotype is low in the population, the OR were quite higher than those previously obtained for single HLA allele associations, with some p values as low as 10(-4). The analysis of the recombinant fragments of these haplotypes allowed the identification of the MHC regions in the 35.1, 35.2, and 44.2 haplotypes associated with rapid progression to AIDS and the MHC regions of the 44.1 and 57.1 haplotypes associated with slow progression to AIDS. Previous studies have identified single HLA alleles associated with disease progression. Our results on recombinant fragments confirm the direct role of HLA-B35 in rapid progression. Associations with HLA-A29 and -B57 might be due to linkage disequilibrium with other causative genes within the MHC region.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12574360     DOI: 10.4049/jimmunol.170.4.1925

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  21 in total

1.  Major histocompatibility complex class IIB allele polymorphism and its association with resistance/susceptibility to Vibrio anguillarum in Japanese flounder (Paralichthys olivaceus).

Authors:  Y X Zhang; S L Chen; Y G Liu; Z X Sha; Z J Liu
Journal:  Mar Biotechnol (NY)       Date:  2006-07-31       Impact factor: 3.619

2.  The degree of HIV-1 amino acid variability is strictly related to different disease progression rates.

Authors:  Rossana Scutari; Monica Faieta; Roberta D'Arrigo; Lavinia Fabeni; Cristina Mussini; Andrea Cossarizza; Claudio Casoli; Carlo Federico Perno; Valentina Svicher; Claudia Alteri; Stefano Aquaro
Journal:  Virus Genes       Date:  2018-05-17       Impact factor: 2.332

3.  Associations of HLA-A, HLA-B and HLA-C alleles frequency with prevalence of herpes simplex virus infections and diseases across global populations: implication for the development of an universal CD8+ T-cell epitope-based vaccine.

Authors:  Sarah Samandary; Hédia Kridane-Miledi; Jacqueline S Sandoval; Zareen Choudhury; Francina Langa-Vives; Doran Spencer; Aziz A Chentoufi; François A Lemonnier; Lbachir BenMohamed
Journal:  Hum Immunol       Date:  2014-05-04       Impact factor: 2.850

4.  Differential clade-specific HLA-B*3501 association with HIV-1 disease outcome is linked to immunogenicity of a single Gag epitope.

Authors:  Philippa C Matthews; Madoka Koyanagi; Henrik N Kløverpris; Mikkel Harndahl; Anette Stryhn; Tomohiro Akahoshi; Hiroyuki Gatanaga; Shinichi Oka; Claudia Juarez Molina; Humberto Valenzuela Ponce; Santiago Avila Rios; David Cole; Jonathan Carlson; Rebecca P Payne; Anthony Ogwu; Alfred Bere; Thumbi Ndung'u; Kamini Gounder; Fabian Chen; Lynn Riddell; Graz Luzzi; Roger Shapiro; Christian Brander; Bruce Walker; Andrew K Sewell; Gustavo Reyes Teran; David Heckerman; Eric Hunter; Søren Buus; Masafumi Takiguchi; Philip J R Goulder
Journal:  J Virol       Date:  2012-09-12       Impact factor: 5.103

5.  Multiple-cohort genetic association study reveals CXCR6 as a new chemokine receptor involved in long-term nonprogression to AIDS.

Authors:  Sophie Limou; Cédric Coulonges; Joshua T Herbeck; Daniëlle van Manen; Ping An; Sigrid Le Clerc; Olivier Delaneau; Gora Diop; Lieng Taing; Matthieu Montes; Angélique B van't Wout; Geoffrey S Gottlieb; Amu Therwath; Christine Rouzioux; Jean-François Delfraissy; Jean-Daniel Lelièvre; Yves Lévy; Serge Hercberg; Christian Dina; John Phair; Sharyne Donfield; James J Goedert; Susan Buchbinder; Jérôme Estaquier; François Schächter; Ivo Gut; Philippe Froguel; James I Mullins; Hanneke Schuitemaker; Cheryl Winkler; Jean-François Zagury
Journal:  J Infect Dis       Date:  2010-09-15       Impact factor: 5.226

6.  Associations of the IL2Ralpha, IL4Ralpha, IL10Ralpha, and IFN (gamma) R1 cytokine receptor genes with AIDS progression in a French AIDS cohort.

Authors:  Hervé Do; Alexandre Vasilescu; Gora Diop; Thomas Hirtzig; Cédric Coulonges; Taoufik Labib; Simon C Heath; Jean-Louis Spadoni; Amu Therwath; Mark Lathrop; Fumihiko Matsuda; Jean-François Zagury
Journal:  Immunogenetics       Date:  2006-02-21       Impact factor: 2.846

7.  Possession of human leucocyte antigen DQ6 alleles and the rate of CD4 T-cell decline in human immunodeficiency virus-1 infection.

Authors:  Annapurna Vyakarnam; David Sidebottom; Shahed Murad; James A Underhill; Philippa J Easterbrook; Angus G Dalgleish; Mark Peakman
Journal:  Immunology       Date:  2004-05       Impact factor: 7.397

8.  Polymorphisms in toll-like receptor 4 and toll-like receptor 9 influence viral load in a seroincident cohort of HIV-1-infected individuals.

Authors:  Samuel O Pine; M Juliana McElrath; Pierre-Yves Bochud
Journal:  AIDS       Date:  2009-11-27       Impact factor: 4.177

Review 9.  Host genetics influences on HIV type-1 disease.

Authors:  Jacques Fellay
Journal:  Antivir Ther       Date:  2009

10.  Genomic analysis of Fas and FasL genes and absence of correlation with disease progression in AIDS.

Authors:  A Vasilescu; S C Heath; G Diop; H Do; T Hirtzig; H Hendel; S Bertin-Maghit; J Rappaport; A Therwath; G M Lathrop; F Matsuda; J-F Zagury
Journal:  Immunogenetics       Date:  2004-03-23       Impact factor: 2.846

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.